Cargando…
Impulse Control Disorders in Parkinson's Disease: Has COVID‐19 Related Lockdown Been a Trigger?
BACKGROUND: Parkinson's disease (PD) patients, especially those on dopamine agonists (DA), are at risk of impulse control disorders (ICD). Little attention has been paid to the influence of environmental factors. CASES: Retrospective analysis of consecutive PD patients seen in our outpatient Mo...
Autores principales: | Rábano‐Suárez, Pablo, Martínez‐Fernández, Raúl, Natera‐Villalba, Elena, Pareés, Isabel, Martínez‐Castrillo, Juan Carlos, Alonso‐Canovas, Araceli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354062/ https://www.ncbi.nlm.nih.gov/pubmed/34405101 http://dx.doi.org/10.1002/mdc3.13276 |
Ejemplares similares
-
SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease
por: Gómez-López, Ana, et al.
Publicado: (2021) -
¿Qué piensan los estudiantes de Medicina sobre los trastornos neurológicos funcionales?
por: Escribano-Paredes, José B., et al.
Publicado: (2023) -
COVID-19 in Parkinson’s disease: what holds the key?
por: Sainz-Amo, R., et al.
Publicado: (2020) -
Transfusion trigger in critically ill patients: has the puzzle been completed?
por: Reiles, Eric, et al.
Publicado: (2007) -
Switching from Rasagiline to Safinamide as an Add-On Therapy Regimen in Patients with Levodopa: A Literature Review
por: Sanchez Alonso, Pilar, et al.
Publicado: (2023)